Hepatitis C Virus Infection Completed Phase 2 / 3 Trials for Ribavirin (DB00811)

DBCOND0033268 (Hepatitis C Virus Infection)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01939197A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 CoinfectionTreatment